迪安诊断(300244) - 2024 Q3 - 季度财报

Financial Performance - Revenue for the third quarter was RMB 3.04 billion, a decrease of 11.89% year-over-year[2] - Net profit attributable to shareholders was RMB 59.11 million, down 23.81% year-over-year[2] - Operating cash flow for the first nine months was RMB 54.2 million, a significant decrease of 85.22% year-over-year[2] - Total assets decreased by 4.81% to RMB 17.08 billion compared to the end of the previous year[2] - Net profit for the quarter decreased to 302.68 million yuan, down from 791.43 million yuan in the same period last year[18] - Sales revenue for the quarter was 9.42 billion yuan, compared to 11.78 billion yuan in the previous year[19] - Operating cash flow for the quarter was 54.20 million yuan, a significant drop from 366.81 million yuan in the same period last year[20] - The company's operating income for the current period was 9,258,110,867.57 yuan, compared to 10,292,194,930.88 yuan in the same period last year[17] - The company's operating costs for the current period were 8,491,254,006.48 yuan, compared to 8,977,566,104.97 yuan in the same period last year[17] Revenue Breakdown - Diagnostic services revenue reached RMB 1.155 billion, with ICL business contributing RMB 1.048 billion[5] - Channel product business revenue was RMB 1.912 billion, while proprietary product revenue was RMB 86 million[5] Expansion and Investments - The company added 4 new precision centers in Q3, bringing the total to 84, with 52 already profitable[6] - International expansion continued with the opening of a testing laboratory in Vietnam[6] - Long-term equity investments increased by 46.71% to RMB 983.57 million due to the acquisition of equity in an associate[5] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 39,463[7] - Chen Haibin, a domestic natural person, holds 26.31% of the shares, totaling 164,438,933 shares, with 123,329,200 shares under restricted sale[7] - Hong Kong Securities Clearing Corporation, an overseas legal entity, holds 3.90% of the shares, totaling 24,355,573 shares[7] - China Bank Limited - Huabao CSI Medical ETF holds 2.73% of the shares, totaling 17,079,326 shares[7] - Hangzhou Dian Holding Co., Ltd., a domestic non-state-owned legal entity, holds 1.70% of the shares, totaling 10,636,390 shares[7] - Xu Min, a domestic natural person, holds 1.60% of the shares, totaling 10,007,933 shares[7] - Morgan Stanley & Co. International PLC, an overseas legal entity, holds 0.78% of the shares, totaling 4,854,440 shares[7] - BNP Paribas - Own Funds, an overseas legal entity, holds 0.77% of the shares, totaling 4,793,600 shares[7] - Cai Ziwei, a domestic natural person, holds 0.74% of the shares, totaling 4,596,900 shares[7] Share Repurchase and Capital Reduction - As of September 30, 2024, the company has repurchased 13,406,000 shares, accounting for 2.14% of the total shares, with a total transaction amount of RMB 193,590,266[12] - The company plans to change the use of repurchased shares from "employee stock ownership plan or equity incentive" to "cancellation and corresponding reduction of registered capital," resulting in the cancellation of 1,918,600 shares and a reduction in total shares from 626,898,036 to 624,979,436[13] Financial Position - As of September 30, 2024, the company's monetary funds decreased to 1,370,982,095.00 yuan from 2,973,332,466.18 yuan at the beginning of the period[14] - The company's accounts receivable increased to 8,366,381,925.24 yuan from 8,054,200,551.87 yuan at the beginning of the period[15] - The company's inventory increased to 1,797,893,772.68 yuan from 1,508,948,754.81 yuan at the beginning of the period[15] - The company's total assets decreased to 17,075,684,838.18 yuan from 17,939,311,256.63 yuan at the beginning of the period[15] - The company's total liabilities decreased to 7,597,898,943.63 yuan from 8,034,531,783.60 yuan at the beginning of the period[16] Expenses and Income - R&D expenses decreased to 225.28 million yuan from 320.48 million yuan in the previous year[18] - Management expenses were reduced to 547.06 million yuan from 650.88 million yuan in the same period last year[18] - Investment income for the quarter was 9.18 million yuan, up from 632,086.78 yuan in the previous year[18] - Income tax expenses decreased by 47.18% to RMB 121.49 million due to lower profit[5] Cash Flow - Cash received from selling goods and providing services was 9.42 billion yuan, down from 11.78 billion yuan in the same period last year[19] - Cash paid for goods and services was 6.43 billion yuan, compared to 7.54 billion yuan in the previous year[20] - Cash paid to employees decreased to 1.62 billion yuan from 2.03 billion yuan in the same period last year[20] - Cash received from investment activities was 569.13 million yuan, down from 948.12 million yuan in the previous year[20] - Net cash flow from investment activities was -622.52 million yuan, a decrease of 85.5% compared to the previous period's -335.63 million yuan[21] - Cash received from investments was 53.12 million yuan, a decrease of 3.8% compared to the previous period's 55.20 million yuan[21] - Cash received from borrowings was 1.43 billion yuan, an increase of 37.5% compared to the previous period's 1.04 billion yuan[21] - Total cash inflow from financing activities was 1.66 billion yuan, an increase of 17.9% compared to the previous period's 1.41 billion yuan[21] - Cash paid for debt repayment was 1.53 billion yuan, a decrease of 41.5% compared to the previous period's 2.62 billion yuan[21] - Cash paid for dividends, profits, or interest payments was 654.08 million yuan, an increase of 62.5% compared to the previous period's 402.56 million yuan[21] - Total cash outflow from financing activities was 2.68 billion yuan, a decrease of 20.3% compared to the previous period's 3.36 billion yuan[21] - Net cash flow from financing activities was -1.02 billion yuan, an improvement of 47.7% compared to the previous period's -1.96 billion yuan[21] - Net increase in cash and cash equivalents was -1.60 billion yuan, an improvement of 17.1% compared to the previous period's -1.93 billion yuan[21] - Ending balance of cash and cash equivalents was 1.35 billion yuan, a decrease of 39.1% compared to the previous period's 2.22 billion yuan[21] Shareholder Pledges - The company's actual controller, Mr. Chen Haibin, and his concerted parties have pledged a cumulative 18.40% of the company's total shares, accounting for 65.69% of their holdings as of September 30, 2024[13]